logo logo
  • HOME
  • ABOUT US
  • CONTACT US
  • IPO
    • Vetted Prospectus
    • IPO Information
    • IPO Utilization Report
    • IPO Related Published News
  • PRODUCTS
    • Tablet
  • ANNUAL REPORTS
    • Annual Report
  • INVESTOR RELATIONS
    • Unclaimed / Unsettled Dividend
    • CG Compliance Status
    • Board of Directors
    • Director's Report
    • Quarterly Report
    • Audited Financial Statements
    • Dividend Distribution Policy
    • Code of Conduct
    • Annual General Meeting
    • PRICE SENSITIVE INFORMATION (PSI)
    • Code of Conduct
    • Corporate Brief
  • MEDIA
  • CAREER
  • WEBMAIL
  • LOGIN

Investor Relations

    PSI on First Quarter Financial Statements 2024-2025 Audit Report & Financial Statements for the year ended 30 June, 2024 Shareholders Information for Annual Report, 2024 Proxy Form & Attendance Slip for AGM 2024 Log in Procedure of 10th AGM, 2024 Notice of the 10th Annual General Meeting 2024 PSI Regarding Record Date, AGM for the year 2023-2024 PSI on 3rd Quarter (Q3) Financial Statements (2023-2024) 3rd Quarter (Q3) Financial Statements (2023-2024) Principles on Disclosure of Material Information and Price Sensitive Information
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • ...
  • 12
  • 13
  • ›
04312174811
04312174977
info@indo-banglapharma.com
Fax: +88-02-57164716 (Ext-101)

VISITOR COUNTER

1 8 8 2 3 6

Quick Links

  • HOME
  • ABOUT US
  • CONTACT US
  • IPO
  • PRODUCTS
  • ANNUAL REPORTS

Quick Links

    • INVESTOR RELATIONS
    • MEDIA
    • CAREER
    • WEBMAIL
    • LOGIN

Copyright © 2025 Indo-Bangla Pharmaceuticals Limited

Develop By : Motaharul Islam